Similar articles

• [Myocardial scintigraphy with Tc-99m-MIBI for assessing the extent and severity of coronary disease: a comparison with thallium-201 and equilibrium angiocardioscintigraphy].

  Leoncini M, Sciagrà R, Bisi G, Santoro GM, Fazzini PF. Leoncini M, et al. G Ital Cardiol. 1993 Feb;23(2):127-38. G Ital Cardiol. 1993. PMID: 8491353 Italian.
• New applications of myocardial perfusion imaging.

  DePuey EG. DePuey EG. Tex Heart Inst J. 1996;23(2):122-7. Tex Heart Inst J. 1996. PMID: 8792543 Free PMC article. No abstract available.
• [Radionuclide imaging using new single-photon tracers].

  Tamaki N, Kawamoto M, Takahashi N, Konishi J. Tamaki N, et al. Kokyu To Junkan. 1991 Nov;39(11):1093-100. Kokyu To Junkan. 1991. PMID: 1837935 Japanese. No abstract available.
• The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.

  Berman DS, Kiat H, Maddahi J. Berman DS, et al. Circulation. 1991 Sep;84(3 Suppl):I7-21. Circulation. 1991. PMID: 1832100 Review.
• Technetium-labeled myocardial perfusion agents.

  Heo J, Iskandrian AS. Heo J, et al. Cardiol Clin. 1994 May;12(2):187-98. Cardiol Clin. 1994. PMID: 8033172 Review.